Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2004 Mar;19(2):153-6.
doi: 10.1007/s00384-003-0531-y. Epub 2003 Sep 13.

A polymorphism of the NFKBIA gene is associated with Crohn's disease patients lacking a predisposing allele of the CARD15 gene

Affiliations
Comparative Study

A polymorphism of the NFKBIA gene is associated with Crohn's disease patients lacking a predisposing allele of the CARD15 gene

Wolfram Klein et al. Int J Colorectal Dis. 2004 Mar.

Abstract

Background and aims: Nuclear factor kappa-B (NFkappaB) plays a crucial role in diseases associated with dysregulated immune response. NFkappaB inhibitor alpha downregulates the activity of NFkappaB.

Patients and methods: To evaluate the contribution of the NFkappaB inhibitor alpha gene in Crohn's disease single nucleotide polymorphisms in the 3'-UTR and at position -420 in the promoter were studied in 259 patients with Crohn's disease genotyped for the variations of the CARD15 gene in comparison to 441 healthy controls. Additionally we screened the coding region of the NFkappaB inhibitor alpha gene for polymorphisms by SSCP analysis.

Results: In comparison to controls the A allele and the AA genotype frequencies of the single nucleotide polymorphisms in the 3'-UTR were significantly increased only in Crohn's disease patients without a variation in the CARD15 gene. Similarly, the difference between patients harboring no predisposing CARD15 alleles and patients harboring such a variation was significant.

Conclusion: The findings indicate that the phenotype Crohn's disease is to be substructured with respect to genetic susceptibility.

PubMed Disclaimer

References

    1. Hum Genet. 1994 Jun;93(6):694-6 - PubMed
    1. Ann N Y Acad Sci. 1998 Nov 17;859:149-59 - PubMed
    1. Gut. 1999 Nov;45(5):693-704 - PubMed
    1. Ann Neurol. 1997 Mar;41(3):341-52 - PubMed
    1. Clin Exp Immunol. 1995 Sep;101(3):428-35 - PubMed

MeSH terms

Substances

LinkOut - more resources